HISTOINDEX AND A*STAR PARTNER TO ADVANCE EARLY-STAGE DEVELOPMENT OF PIPELINE THERAPIES FOR FIBROTIC DISEASES
SINGAPORE, Oct. 19, 2026 /PRNewswire/ -- HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, have signed a Memorandum of Understanding (MoU) to collaborate on the preclinical evaluation and characterization of therapeutic candidates for various fibrotic diseases, including cancer-associated fibrosis. Dr...
ESMO 2026 Preview | Mabwell to Present Clinical Results for Nectin-4-Targeting ADC 9MW2821 in ADC-Pretreated Triple-Negative Breast Cancer
SHANGHAI, Oct. 19, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, will present Phase II clinical data on its Nectin-4-targeting antibody-drug conjugate (ADC) 9MW2821 (Bulumtatug Fuvedotin, "BFv") in locally advanced or metastatic triple-negative breast cancer (TNBC) as an oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress....
UEG Week 2026: Antibiotic use from childhood linked to higher odds of IBS in young adulthood
BARCELONA, Spain, Oct. 19, 2026 /PRNewswire/ -- Antibiotic use from childhood through early adulthood is associated with higher odds of irritable bowel syndrome (IBS) at age 24, with the odds increasing as the number of antibiotic prescriptions rose, according to a new study presented today at UEG Week 2026. Researchers analysed data from 2,853 participants in the Swedish...
Abu Dhabi Health Delegation Concludes Inaugural Visit to China, Opening New Pathways to Advance AI, Precision Medicine and Next-Gen Therapies
ABU DHABI, UAE, Oct. 18, 2026 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has concluded its inaugural health and life sciences mission to China, advancing priority areas of collaboration designed to accelerate the translation of scientific and technological innovation...
Paris Court Ruling on Discontinued Feature Will Have Minimal Impact on Angelalign Customers
Angelalign Has Already Replaced Torque Ridges with Upgraded "Pressure Points" in Europe SAN CLEMENTE, Calif., Oct. 17, 2026 /PRNewswire/ -- Angelalign Technology Inc. (6699.HK) ("Angel") http://www.angelaligner.com, a company driven by innovation in orthodontic clear aligner technology, said today that a ruling by the Paris Local Division of the Unified Patent Court...
BCRF Launches $100 Million Venture Program for Breast Cancer: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Oct. 16, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. VSCO launches nationwide photography campaign...
BCRF Launches $100 Million Venture Program for Breast Cancer: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Oct. 16, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. VSCO launches nationwide photography campaign...
World Gym Announces Second Bangkok Location, Plans for 30 Thailand Locations in Five Years
Global Fitness Brand Signs Lease for Second Bangkok Location with Singha Estate, a Leading Thai Real Estate Developer. BANGKOK, Oct. 16, 2026 /PRNewswire/ -- World Gym Corporation (TWSE: 2762), Taiwan's largest fitness operator and owner of the global World Gym brand, today announced that it has signed a lease for its second Bangkok club at S-OASIS, a commercial...
Jyong Biotech Announces Proposed Texas Facility to Support Potential Commercialization of Its Drug Candidates
NEW TAIPEI CITY, Oct. 16, 2026 /PRNewswire/ -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics, today announced that it plans to establish a potential new manufacturing facility and U.S. operations center in Texas. The initiative is intended to support the Company's U.S. operations...
Pope Leo XIV’s Lung Cancer Diagnosis Puts Spotlight on Hope and Advances in Treatment
IASLC highlights global collaboration, advancing lung cancer care and bringing new hope to patients and families. DENVER, Oct. 15, 2026 /PRNewswire/ -- Pope Leo XIV's diagnosis of lung adenocarcinoma has brought global attention to a disease that affects millions of individuals and families across every community. Lung cancer is among the most common diagnosed cancers worldwide, with approximately...
